American College of Clinical Pharmacy
      Search      Cart
         

SCHEDULE

GI/Liver/Nutrition PRN Focus Session — Evolving Horizons in Inflammatory Bowel Disease: Contemporary Pharmacotherapy and Emerging Therapeutic Targets​

Tuesday, October 20, 2026 from 10:15 a.m. to 11:45 a.m. MDT at Salt Palace Convention Center - Ballroom I

Available for 1.50 hours of CPE credit
Activity Number: 0217-0000-26-157-L01-P
Activity Type: An Application-Based Activity

Management of inflammatory bowel disease (IBD) continues to advance rapidly, with expanding biologic classes, novel small molecules, and evolving strategies for positioning therapy across disease phenotypes. This session will synthesize recent guideline updates, pivotal clinical trial data, and practical considerations for enhancing treatment selection, monitoring, and optimization. Emphasis will be placed on actionable, pharmacy-focused insights to support evidence-based care in both ambulatory and acute care settings.​

Learning Objectives

1. ​Summarize current inflammatory bowel disease (IBD) treatment goals.​ 

2. ​​​​Differentiate emerging therapeutic options used for inflammatory bowel disease management.​​​  

3. Interpret recent guideline updates and pivotal clinical trial data to inform acute inpatient management of IBD.  

4. ​​​Apply guideline recommendations and clinical trial evidence to outpatient IBD management decisions.​​ 

5. ​​​Analyze treatment positioning and sequencing strategies across IBD therapies based on disease severity, risk stratification, and prior treatment exposure.​​  

6. ​​​Design care plans that incorporate individualized and evidence-based treatment strategies for patients with IBD.​​  

Michael A. Rudoni, Jr., Pharm.D., FCCM, BCCCP, BCPS
Moderator:Michael A. Rudoni, Jr., Pharm.D., FCCM, BCCCP, BCPS

IBD Management Reimagined: Decoding Today’s Therapeutic Landscape

10:15 a.m. to 10:45 a.m.
Shubha Bhat, Pharm.D., FCCP, BCACP
Speaker:Shubha Bhat, Pharm.D., FCCP, BCACP
Clinical Pharmacist - Gastroenterology/Hepatology
Cleveland Clinic Foundation
Cleveland, Ohio
  View Biography

From Evidence to Action: Navigating Modern IBD Therapeutics

10:45 a.m. to 11:15 a.m.
Gregory Zumach, Pharm.D., BCPS
Speaker:Gregory Zumach, Pharm.D., BCPS
Clinical Assistant Professor, Oregon State University College of Pharmacy;
Clinical Pharmacist, Good Samaritan Regional Medical Center
Corvallis, Oregon
  View Biography

Bridging the Gap: Case-Based Decision Making Across the IBD Care Continuum

11:15 a.m. to 11:45 a.m.
David K. Choi, Pharm.D.
Speaker:David K. Choi, Pharm.D.
Associate Director
Clinical Pharmacy Specialist
University of Chicago Medicine
Inflammatory Bowel Disease Center
Chicago, Illinois

Cookies

This website uses cookies to help ACCP provide you with the best user experience. If you continue to use our services, ACCP will assume that you agree to the use of such cookies. You can find out how to update your settings by referring to ACCP’s Policy on Cookies.